GlaxoSmithKline a global healthcare company that develops, manufactures and markets pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. I have a holding in my income portfolio (epic code: GSK).
GSK announced today that they had received U.S. FDA approval for Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with melanoma that cannot be removed by surgery or melanoma which has spread to other parts of the body.
The original application was made in early July 2013, based on data from a phase I & II study.
No comments:
Post a Comment